Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Grey Sky Venture Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 3
Rounds per year 0.88
Lead investments 1
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Medical
  • Biotechnology
  • Therapeutics
  • Augmented Reality
  • Medical Device
Summary

The main office of represented VC is situated in the Bellevue. The fund was located in North America if to be more exact in United States.

The overall number of key employees were 3.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Medical Device, mHealth. Among the most popular portfolio startups of the fund, we may highlight Sonavex, Biolinq, Altoida.

When the investment is from Grey Sky Venture Partners the average startup value is 10-50 millions dollars. The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Grey Sky Venture Partners, startups are often financed by VI Partners AG, Fyrfly Venture Partners, Alpana Ventures. The meaningful sponsors for the fund in investment in the same round are Mitsubishi UFJ Capital, M Ventures, Hikma Ventures. In the next rounds fund is usually obtained by National Institutes of Health, Pangaea Ventures, National Science Foundation.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bank Muscat Masqat, Muscat, Oman
Bowman Capital California, San Mateo, United States
Cheetah Mobile Beijing, Beijing, China
Columbia Ventures Corporation -
EBI Investment China, Shanghai
Grape Arbor VC New York, New York, United States
Gunderson Dettmer California, Redwood City, United States
Huntington National Bank Columbus, Ohio, United States
Innovatus Capital Partners New York, New York, United States
Khwarizmi Ventures Ash Sharqiyah, Eastern Region, Saudi Arabia
Less Plastics Canada, Gatineau, Quebec
LKJ Capital Japan -
NCrypted Technologies Ahmedabad, Gujarat, India
OCV California, Los Angeles, United States
Qinglan Capital -
Shandong Best Power Investment China, Jinan, Shandong
Surround Ventures New York, New York, United States
Technicolor California, United States, West Hollywood
Wensu Investment -
West Health Investment Fund California, La Jolla, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AmacaThera

Biopharma
Biotechnology
Therapeutics
$2M03 Oct 2019 Old Toronto, Ontario, Canada

Altoida, Inc.

Application Software
Augmented Reality
Diagnostic Equipment
Health Care
Health Diagnostics
Medical
Medical Device
mHealth
Other Healthcare Technology Systems
Software
$6M23 May 2019 Washington, District of Columbia, United States

HepaTx

Biotechnology
Medical
Therapeutics
$2M20 Aug 2018 Palo Alto, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Grey Sky Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 1M
Rounds per year 0.88
Peak activity year 2019
Lead investments 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AmacaThera

Biopharma
Biotechnology
Therapeutics
$2M03 Oct 2019 Old Toronto, Ontario, Canada

Altoida, Inc.

Application Software
Augmented Reality
Diagnostic Equipment
Health Care
Health Diagnostics
Medical
Medical Device
mHealth
Other Healthcare Technology Systems
Software
$6M23 May 2019 Washington, District of Columbia, United States

HepaTx

Biotechnology
Medical
Therapeutics
$2M20 Aug 2018 Palo Alto, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: